OKYO Pharma OKYO
NASDAQ OKYO
$1.54 +0.17 (+12.41%)
At close: Oct 21, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Capital Expenditures (2026)

Updated

OKYO Pharma's Capital Expenditures was -$4.87 billion in the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Capital Expenditures (2026) Analysis & Trends

For the year ended Mar 31, 2026, Capital Expenditures at OKYO Pharma came in at -$6.08 billion.

  • In earlier years, Capital Expenditures was -$1.21 billion in the year ended Mar 31, 2025, -$5.92 billion in the year ended Dec 31, 2023 and -$2.28 billion in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 OKYO Pharma 1.03 Bn 999.20 Mn - 1.21 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.21 Bn
API Access

OKYO Pharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=OKYO&period=max&api_key=YOUR_API_KEY